Elsevier / MEDai Enhances Real-Time Clinical Surveillance System for Hospitals

Pinpoint Review® enhancements allow hospitals and clinicians to provide safer, more efficient and less costly care

ORLANDO, FL - Elsevier / MEDai, a leading provider of advanced clinical analytic healthcare solutions, announced today the launch of the latest version of Pinpoint Review®, its real-time, clinical surveillance system for hospitals. The new version will feature an expanded set of clinical watch triggers, expanded core measure alerts and three new predictions: ICU Admission Prediction, Length of Stay Prediction and Mortality Prediction.

“Hospitals are facing an enormous amount of pressure to provide better, safer care with fewer complications while managing costs,” said Swati Abbott, President of Elsevier / MEDai. “Elsevier / MEDai has enhanced its predictive analytics product to continuously give hospitals and clinicians the most up-to-date tools they need to lower mortality rates and healthcare costs, provide a higher quality of care, increase patient safety and maintain regulatory compliance.”

Pinpoint Review generates predictions for acute-care patients, focusing on the likelihood of a patient developing a complication, contracting a healthcare-acquired infection or being readmitted within 30 days of discharge, while patients are still in the hospital and there is time to adjust care to avoid a negative outcome.

With the expansion of Pinpoint Review’s new predictions, care givers are able to enhance their efforts in proactive care management. Pinpoint Review unlocks the power of clinical and administrative hospital data by utilizing predictive technologies to turn data into actionable information. Empowering today’s hospitals with the ability to predict whether or not a patient will be admitted to the ICU or higher intensity care unit, a predicted length of hospital stay or patient expiration goes a long way in driving down the cost of care and brings a proactive approach to quality improvement.

Pinpoint Review addresses the increasing pressure on hospitals from entities such as the Agency for Healthcare Research and Quality and the Joint Commission on Accreditation of Healthcare Organizations to deliver a higher quality of care and fewer medical errors. Pinpoint Review alerts care providers to patients at risk for developing several of the conditions that the Centers for Medicare and Medicaid Services (CMS) no longer reimburse.

Additional Elsevier / MEDai tools include Pinpoint Quality® and Pinpoint Compliance®. Pinpoint Quality provides robust retrospective outcomes analysis that helps hospitals and physicians quickly identify areas for improvement, making it possible for clinicians to improve performance, outcomes, patient satisfaction, efficiency and cost savings by understanding the drivers of the negative outcomes and allowing them to compare their performance against national standard benchmarks. Pinpoint Compliance® provides a simple, time-saving Web-based solution for organizations to collect, report and submit data to the Joint Commission, CMS, and other regulatory reporting agencies, while participating in initiatives related to accreditation, quality improvement and compliance.

For more information, please visit External link www.medai.com or call 800-446-3324.

# # #

About Elsevier / MEDai
Elsevier / MEDai, Inc., is a subsidiary of Elsevier, a world-leading publisher of more than 2,000 scientific, technical and medical information products and services. Elsevier / MEDai offers award-winning solutions for the improvement of healthcare delivery. Utilizing cutting-edge technology, payors and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time and improve outcomes. For more information on Elsevier / MEDai, visit www.medai.com.

About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (External link www.thelancet.com) and Cell (External link www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include SciVerse ScienceDirect (External link www.sciencedirect.com), SciVerse Scopus (External link www.scopus.com), Reaxys (External link www.reaxys.com), MD Consult (External link www.mdconsult.com) and Nursing Consult (External link www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (External link www.scival.com) and Elsevier / MEDai’s Pinpoint Review (External link www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (External link www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (External link www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).